Adicet Bio, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26±39.1%▼−13.43%×0.34

quarterimplied−40%0+40%realized×

Q2 FY26±39.1%▼−13.43%×0.34

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

Bull2

56managers reporting a position in the latest quarterly filings13F · Jun 30 '26

4 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

Bear2

100.00%of revenue from the largest disclosed customer Regeneron PharmaceuticalsSEC filings

−6.10%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

ACET report session

No linked exposure.

Oct 21impliedImplied move: ±69.5% into Nov 4 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.